Trial Profile
Randomized cross-over study of mirabegron and vibegron in female overactive bladder
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2024
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Vibegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 02 Mar 2024 Results (n=83)published in the World Journal of Urology
- 07 Jun 2019 Status changed from not yet recruiting to recruiting.
- 06 Dec 2018 New trial record